Arvee Laboratories (India) Ltd. ARVEE NSEINFRA
Company Overview
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
Recent Developments
- Mar 2025 Revenue of ₹38.44 Cr (+26.7% YoY); net profit ₹2.15 Cr.
- Trailing 12 Months Year-on-year growth — revenue +130.3%, earnings +926.7%.
- 5-Year Trend Long-term compounding — revenue CAGR -1.1%, profit CAGR -5.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -1.06% |
| 1 Year: | 130.30% |
Compounded Profit Growth
| 5 Years: | -5.86% |
| 1 Year: | 926.70% |
Stock Price Performance
| 1 Year: | +16.79% |
| 6 Months: | +19.80% |
| 3 Months: | +24.62% |
| 1 Month: | -5.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)46.31 · Neutral
P/E of 53.64 is above the sector median of 20.95 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 53.6.
- Revenue declined at -1.1% CAGR over 5 years.
- Earnings shrank at -5.9% CAGR over 5 years.
- Trading 32.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ARVEE Arvee Laboratories (India) Ltd. NSEINFRA | 197.38 | 53.64 | ₹217.51 Cr | 0.00% | 8.95% | 6.87% | -1.06% | -5.86% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 10,958.00 | 37.77 | ₹3.22 L Cr | 2.25% | 11.84% | 10.66% | 11.92% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,220.00 | 12.04 | ₹2.98 L Cr | 0.58% | 18.75% | 22.30% | 3.61% | 75.28% |
| 4 | ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA | 2,284.80 | 45.45 | ₹2.19 L Cr | 1.19% | 24.41% | 20.24% | 1.10% | 1.75% |
| 5 | HINDZINC Hindustan Zinc Limited NSEINFRA | 518.00 | 12.82 | ₹2.19 L Cr | 2.07% | 61.97% | 61.13% | 5.61% | 9.58% |
| 6 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 172.33 | 19.47 | ₹2.15 L Cr | 2.33% | 11.32% | 10.56% | -1.59% | 7.21% |
| 7 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 885.60 | 12.01 | ₹1.97 L Cr | 0.56% | 9.42% | 9.80% | 7.10% | 9.87% |
| 8 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 2,894.40 | 34.52 | ₹1.96 L Cr | 0.35% | 3.98% | 4.80% | 14.30% | -10.06% |
| 9 | SOLARINDS Solar Industries India Limited NSEINFRA | 19,010.00 | 86.39 | ₹1.72 L Cr | 0.06% | 29.51% | 26.72% | 12.39% | 30.36% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | 8.91 Cr | 6.40 Cr | 7.48 Cr | 3.45 Cr | 9.78 Cr |
| Cost of Revenue | - | 5.24 Cr | 6.55 Cr | 3.42 Cr | 12.32 L | 4.80 Cr |
| Gross Profit | - | 3.67 Cr | -15.08 L | 4.06 Cr | 3.33 Cr | 4.98 Cr |
| Operating Expenses | - | 3.59 Cr | -10.69 L | 4.01 Cr | 3.50 Cr | 3.65 Cr |
| Operating Income | - | 7.29 L | -4.38 L | 4.88 L | -17.55 L | 1.32 Cr |
| EBITDA | - | 53.53 L | 33.41 L | 51.16 L | 35.70 L | 1.76 Cr |
| Interest Expense | - | 5.34 L | -2.78 L | 4.33 L | 4.38 L | 6.59 L |
| Pretax Income | - | 20.68 L | 9.36 L | 17.42 L | 1.03 L | 1.39 Cr |
| Tax Provision | - | 5.20 L | 2.45 L | 51,000 | 2,000 | -43.47 L |
| Net Income | - | 15.48 L | 6.91 L | 16.91 L | 1.01 L | 1.83 Cr |
| Diluted EPS | 0.89 | 0.14 | - | 0.15 | 0.01 | 1.66 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 39.69 Cr | 61.28 Cr | 30.34 Cr | 38.44 Cr |
| Cost of Revenue | 25.88 Cr | 43.97 Cr | 18.76 Cr | 24.93 Cr |
| Gross Profit | 13.81 Cr | 17.31 Cr | 11.58 Cr | 13.51 Cr |
| Operating Expenses | 10.81 Cr | 12.07 Cr | 10.09 Cr | 11.05 Cr |
| Operating Income | 3.00 Cr | 5.24 Cr | 1.49 Cr | 2.46 Cr |
| EBITDA | 6.15 Cr | 8.53 Cr | 3.52 Cr | 4.17 Cr |
| Interest Expense | 31.50 L | 28.56 L | 18.77 L | 15.10 L |
| Pretax Income | 3.45 Cr | 6.17 Cr | 1.83 Cr | 2.87 Cr |
| Tax Provision | 87.52 L | 2.05 Cr | 77.77 L | 72.35 L |
| Net Income | 2.57 Cr | 4.12 Cr | 1.05 Cr | 2.15 Cr |
| Diluted EPS | 2.34 | 3.74 | 0.95 | 1.95 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | 38.68 Cr | 38.69 Cr | 38.56 Cr | 37.57 Cr |
| Current Assets | 22.16 Cr | 21.57 Cr | 16.98 Cr | 19.66 Cr |
| Cash & Equivalents | 1.28 Cr | 53.75 L | 1.85 Cr | 21.10 L |
| Inventory | 5.73 Cr | 4.57 Cr | 6.40 Cr | 4.55 Cr |
| Receivables | 12.13 Cr | 12.26 Cr | 6.11 Cr | 8.40 Cr |
| Total Liabilities | 14.74 Cr | 10.62 Cr | 9.45 Cr | 6.31 Cr |
| Current Liabilities | 13.29 Cr | 8.84 Cr | 7.13 Cr | 3.83 Cr |
| Long Term Debt | 1.00 Cr | 1.00 Cr | 1.00 Cr | 1.03 Cr |
| Total Debt | 3.13 Cr | 1.00 Cr | 1.00 Cr | 1.03 Cr |
| Total Equity | 23.94 Cr | 28.06 Cr | 29.11 Cr | 31.26 Cr |
| Shares Outstanding | 1.10 Cr | 1.10 Cr | 1.10 Cr | 1.10 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 68.13 L | 2.93 Cr | 3.66 Cr | -20.62 L |
| Investing Cash Flow | 5.93 L | -1.26 Cr | -2.16 Cr | -1.32 Cr |
| Financing Cash Flow | -6.06 Cr | -2.42 Cr | -18.77 L | -11.77 L |
| Capital Expenditure | -2.36 Cr | -1.48 Cr | -2.59 Cr | -1.85 Cr |
| Free Cash Flow | -1.68 Cr | 1.44 Cr | 1.08 Cr | -2.06 Cr |
| Net Change in Cash | -5.32 Cr | -74.56 L | 1.31 Cr | -1.64 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Gross Margin % | 34.8% | 28.2% | 38.2% | 35.1% |
| Operating Margin % | 7.6% | 8.6% | 4.9% | 6.4% |
| Net Margin % | 6.5% | 6.7% | 3.5% | 5.6% |
| ROE % | 10.8% | 14.7% | 3.6% | 6.9% |
| ROCE % | 11.8% | 17.6% | 4.7% | 7.3% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ARVEE
Arvee Laboratories Share Price News After Latest Decline - Univest
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNQXBIMkJpMEZWRndRQ3ZCd0NyOEJ2R0xoUTBtWjRUZkFHa1VjNTRpeUw4ellnTFZKRENYRnFhbUg1ajRpR0pqbGVsUFJDbkNKYmFHSndDNlZuX0NxZGIxc0I5dVBXR3VHYzI1VW5IZkcyYlMtbEFCR0lfOXhQOUZVTnljUC0tNEpt?oc=5"…
Arvee Laboratories Stock: Daily Chart Analysis - Kalkine India
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPcXlySmlaLS1BM3Nfb2R6M2tkMzRIbWVuNGZNRGZVMml5OU56czRtN3BHR3RNMXVYanhEazlPTUZud042NlF6aEUwNUFvZV96Vk45N0h6YjJVVWdaTGtHTFJDWUlabTJERFZDNjVDeThxcGVaLTRjeW1UUFhtaUFwdW5ta2NhZmd2MTlSTF…
If EPS Growth Is Important To You, Arvee Laboratories (India) (NSE:ARVEE) Presents An Opportunity - Simply Wall Street
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQT1g1RGpBWnA5QmFEQ2lDYkRTX0NoT19sWnFGa2VoX2xZT3JkdmZSZmNGR1BqSVFyeHZUZ2pCaEszOEU1N0EyaDBCWGxGVnd1N0Fjc2hwbUNaNzNjV19wbEh0TVczTEszNF81dTRzcXJLTFBSYVZOZGpQLWtNTjcxOTZ3Z213UjR5V0xmR2…
Arvee Laboratories (India) Ltd. Share Price Live Today - CNBC TV18
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPSzNwWEhKV2tLb1pyUW5FWGtYRS1uOUNTYkYxUGlzUE5Sd3ladTA3SFl6WXdWRjFQdEpHVnlyekhkV0JZZ2dnWlIxQkFmazgyQU9lRzV6STRWcTVoa1plTC1DdlRIVUZuUjdYak91OUxLRnJhYWdyNzM1R0tsNkFVYnNGU3NsRzdnblJhME…
Arvee Laboratories (ARVEE.NS) Edges Up 1.43% to ₹237.85, Holds Above Key Support - Institutional Flow Picks - https://www.siam.in/
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPLXBkZXAzeXJ5ZjhDVG5kOFhqZlB6LVBiak4xS1VaaERsSE5jRWJWN0tnWHpJVVJDbzZ6ZllOWFNMaFVrNUFGZFI2bVJRcXBGT3lCdWFOWHhLd0ZQUThVdlN0SDdFRlQyUnhtZndYb3BaZkFsVTFCMlNqLWYwbUh1Sk1wcGxiYnVhZUxQLW…
Arvee Laboratories (India) Ltd is Rated Hold by MarketsMOJO - MarketsMojo
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNUXhWSGo0bjRsZ2w0UkZiNkhja2JXUGdjRk5Vdkw0WG93NTNJTXQ3cmMwbGNjX3R1WjNnc3ZueDBkQ2tOQlhXOW1KODBWUGRKMW9VdWVOdW1IMW42cVBPSHF1V2xqZ0trOHRka3Uwa0FZU245ck1hcmZVRnFZMmpiZlRhYjZoMzQ5X2ktMG…
ARVEE — Frequently Asked Questions
What is the current share price of Arvee Laboratories (India) Ltd. (ARVEE)?
As of 2026-10-24 04:55 IST, Arvee Laboratories (India) Ltd. (ARVEE) trades at ₹197.38 on NSE. Its 52-week range is ₹133.86 to ₹290.78.
What is the market capitalisation of ARVEE?
Arvee Laboratories (India) Ltd. (ARVEE) has a market capitalisation of ₹217.51 Cr on NSE.
What is the P/E ratio of ARVEE?
ARVEE trades at a trailing price-to-earnings (P/E) ratio of 53.64. The industry average P/E is 20.95. Its price-to-book (P/B) ratio is 6.78.
What is the return on equity (ROE) of ARVEE?
ARVEE has a return on equity (ROE) of 6.87%. Its return on capital employed (ROCE) is 8.95%.
Is ARVEE a good stock to buy?
This page provides a data-driven analysis of Arvee Laboratories (India) Ltd. (ARVEE), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.